ChromaDex (NASDAQ:CDXC) Issues Quarterly Earnings Results

ChromaDex (NASDAQ:CDXC) released its earnings results on Thursday. The company reported $0.02 earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $25.58 million for the quarter, compared to analyst estimates of $23.70 million. ChromaDex had a net margin of 1.62% and a return on equity of 5.06%. During the same period in the prior year, the firm earned ($0.01) EPS. ChromaDex updated its FY 2024 guidance to EPS.

ChromaDex Trading Up 67.9 %

NASDAQ CDXC traded up $2.37 on Friday, hitting $5.86. 37,543,352 shares of the stock traded hands, compared to its average volume of 264,220. The company has a market capitalization of $444.95 million, a P/E ratio of 586.59 and a beta of 1.88. The stock has a 50-day moving average of $3.53 and a 200 day moving average of $3.23. ChromaDex has a twelve month low of $1.32 and a twelve month high of $5.98.

Insider Buying and Selling

In other ChromaDex news, Director Kristin Patrick sold 23,000 shares of ChromaDex stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $3.57, for a total value of $82,110.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 9.64% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and issued a $6.00 target price on shares of ChromaDex in a research report on Friday, August 9th.

ChromaDex Company Profile

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.